skip to Main Content

COVID-19 vaccines have been FDA approved for children and teens age 5-17 years old. We recommend that children with multiple sclerosis and other demyelinating disorders should be vaccinated with the COVID-19 vaccine.

For more guidance, please visit the National MS Society’s website.

Back To Top